Zota Health Care Ltd.(IN:ZOTA)
₹1,297.10-5.60 (-0.43%)
IN:ZOTA
Zota Health Care Ltd. financials statements
₹1,297.10
At close:-5.60 (-0.43%)
Want to see IN:ZOTA full AI Analyst Report?
Zota Health Care Ltd. (ZOTA) Ratios
0 Followers
Zota Health Care Ltd. Ratios
IN:ZOTA's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:ZOTA's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.93 | 1.83 | 1.51 | 2.08 | 2.14 |
| Quick Ratio | 1.11 | 0.78 | 0.79 | 1.05 | 1.33 |
| Cash Ratio | 0.40 | 0.02 | 0.01 | 0.00 | 0.00 |
| Solvency Ratio | 0.02 | -0.06 | 0.04 | 0.08 | 0.25 |
| Operating Cash Flow Ratio | -0.33 | -0.50 | -0.08 | -0.05 | 0.37 |
| Short-Term Operating Cash Flow Coverage | -3.53 | -81.98 | -0.41 | -0.23 | 5.47 |
| Net Current Asset Value | ₹ 222.80M | ₹ -278.23M | ₹ -267.34M | ₹ 64.13M | ₹ 274.38M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.24 | 0.32 | 0.42 | 0.29 | 0.11 |
| Debt-to-Equity Ratio | 0.39 | 0.62 | 1.06 | 0.56 | 0.17 |
| Debt-to-Capital Ratio | 0.28 | 0.38 | 0.51 | 0.36 | 0.14 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.63 | 1.96 | 2.54 | 1.97 | 1.55 |
| Debt Service Coverage Ratio | 0.61 | -0.24 | 0.51 | 0.76 | 4.68 |
| Interest Coverage Ratio | -3.68 | -4.54 | -2.63 | -1.74 | 35.04 |
| Debt to Market Cap | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 |
| Interest Debt Per Share | 87.43 | 54.74 | 39.02 | 18.95 | 6.12 |
| Net Debt to EBITDA | 9.43 | -37.51 | 11.61 | 4.59 | 0.90 |
| Profitability Margins | |||||
| Gross Profit Margin | 11.86% | 53.13% | 44.51% | 22.20% | 31.93% |
| EBIT Margin | -11.87% | -15.99% | -6.63% | -1.54% | 9.67% |
| EBITDA Margin | 3.44% | -1.25% | 4.50% | 7.01% | 12.52% |
| Operating Profit Margin | -11.87% | -16.70% | -6.99% | -3.19% | 8.54% |
| Pretax Profit Margin | -14.82% | -19.68% | -8.96% | -3.35% | 9.48% |
| Net Profit Margin | -13.73% | -19.25% | -7.95% | -4.12% | 6.79% |
| Continuous Operations Profit Margin | -13.75% | -19.37% | -7.95% | -4.12% | 6.79% |
| Net Income Per EBT | 92.61% | 97.84% | 88.77% | 123.06% | 71.63% |
| EBT Per EBIT | 124.91% | 117.81% | 128.15% | 105.08% | 110.98% |
| Return on Assets (ROA) | -6.54% | -12.84% | -6.28% | -3.65% | 6.40% |
| Return on Equity (ROE) | -10.66% | -25.21% | -15.95% | -7.18% | 9.94% |
| Return on Capital Employed (ROCE) | -7.15% | -14.45% | -8.16% | -3.80% | 10.86% |
| Return on Invested Capital (ROIC) | -6.09% | -13.00% | -5.99% | -3.30% | 7.43% |
| Return on Tangible Assets | -6.64% | -12.99% | -6.40% | -3.75% | 6.67% |
| Earnings Yield | -2.11% | -2.52% | -1.17% | -0.81% | 1.20% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.47 | 5.10 | 3.57 | 3.79 | 2.91 |
| Payables Turnover | 4.54 | 3.24 | 2.98 | 4.12 | 4.78 |
| Inventory Turnover | 2.46 | 1.30 | 1.86 | 2.61 | 3.09 |
| Fixed Asset Turnover | 1.47 | 1.57 | 1.74 | 2.30 | 5.55 |
| Asset Turnover | 0.48 | 0.67 | 0.79 | 0.89 | 0.94 |
| Working Capital Turnover Ratio | 3.55 | 4.82 | 4.42 | 3.31 | 3.13 |
| Cash Conversion Cycle | 149.37 | 239.85 | 175.58 | 147.62 | 167.35 |
| Days of Sales Outstanding | 81.68 | 71.63 | 102.10 | 96.24 | 125.46 |
| Days of Inventory Outstanding | 148.10 | 280.94 | 195.95 | 140.08 | 118.31 |
| Days of Payables Outstanding | 80.42 | 112.72 | 122.48 | 88.69 | 76.42 |
| Operating Cycle | 229.78 | 352.57 | 298.06 | 236.31 | 243.77 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -24.00 | -18.19 | -2.33 | -0.80 | 5.36 |
| Free Cash Flow Per Share | -58.31 | -34.92 | -8.85 | -5.77 | 4.05 |
| Dividend Paid and CapEx Coverage Ratio | -0.68 | -1.03 | -0.31 | -0.12 | 2.31 |
| Capital Expenditure Coverage Ratio | -0.70 | -1.09 | -0.36 | -0.16 | 4.10 |
| Operating Cash Flow Coverage Ratio | -0.29 | -0.36 | -0.06 | -0.04 | 0.89 |
| Operating Cash Flow to Sales Ratio | -0.15 | -0.17 | -0.03 | -0.01 | 0.10 |
| Free Cash Flow Yield | -5.48% | -4.29% | -1.84% | -2.05% | 1.36% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -47.41 | -39.66 | -85.80 | -122.80 | 83.14 |
| Price-to-Sales (P/S) Ratio | 6.51 | 7.63 | 6.82 | 5.07 | 5.64 |
| Price-to-Book (P/B) Ratio | 5.05 | 10.00 | 13.68 | 8.82 | 8.26 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -18.26 | -23.31 | -54.25 | -48.87 | 73.44 |
| Price-to-Operating Cash Flow Ratio | -44.36 | -44.77 | -205.72 | -353.37 | 55.55 |
| Price-to-Earnings Growth (PEG) Ratio | -5.04 | -0.15 | -0.60 | 0.75 | -0.02 |
| Enterprise Value Multiple | 198.50 | -647.84 | 163.20 | 76.89 | 45.99 |
| Enterprise Value | 36.80B | 23.74B | 13.25B | 7.54B | 7.55B |
| EV to EBITDA | 198.50 | -647.84 | 163.20 | 76.89 | 45.99 |
| EV to Sales | 6.83 | 8.10 | 7.34 | 5.39 | 5.76 |
| EV to Free Cash Flow | -19.17 | -24.75 | -58.40 | -51.98 | 74.91 |
| EV to Operating Cash Flow | -46.58 | -47.52 | -221.47 | -375.81 | 56.66 |
| Tangible Book Value Per Share | 205.98 | 80.89 | 33.50 | 30.23 | 33.82 |
| Shareholders’ Equity Per Share | 210.67 | 81.42 | 35.09 | 31.94 | 36.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.07 | 0.02 | 0.11 | -0.23 | 0.28 |
| Revenue Per Share | 163.63 | 106.64 | 70.38 | 55.63 | 52.72 |
| Net Income Per Share | -22.46 | -20.53 | -5.59 | -2.29 | 3.58 |
| Tax Burden | 0.93 | 0.98 | 0.89 | 1.23 | 0.72 |
| Interest Burden | 1.25 | 1.23 | 1.35 | 2.18 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.24 | 0.26 | 0.16 | 0.14 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.07 | 0.87 | 0.42 | 0.43 | 1.07 |
Currency in INR
